236 Studies Now Enrolling
Menu
Search
Medical Condition
- Show all (1001)
- Addiction (14)
- Allergy, Asthma, & Immunology (11)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (25)
- Blood Disorders (18)
- Bone & Muscle (8)
- Cancer (90)
- Child Development (4)
- COVID-19 (Coronavirus) (28)
- Critical Illness (1)
- Diabetes (13)
- Ear, Nose and Throat (5)
- Endocrine & Metabolic Disease (11)
- Eye (7)
- Gastrointestinal and Digestive Diseases (23)
- Hair and Skin Disorders (2)
- Headaches (5)
- Healthy Volunteers (142)
- Heart Disease (111)
- Infectious Disease (40)
- Insomnia (2)
- Kidney Disease (12)
- Liver Disease (43)
- Lung Disease (29)
- Meniere's Disease (1)
- Neurological Disorders (96)
- Nutrition (3)
- Obesity (2)
- Obstetrics & Gynecology (46)
- Pain Management (1)
- Pediatrics (83)
- Psychiatric Disorders (60)
- Rehabilitation (7)
- Stroke (5)
- Surgery (7)
- Transplant (33)
- Urology (3)
- Vascular Conditions (9)
Displaying 1 - 2 of 2
Condition: Blood Disorders / Anemia
Investigator: Katherine Ender, MD
Status: Closed
The main purpose of the study is to find out whether Triferic, when taken by mouth (orally) with Shohls solution, is safe and effective for the treatment of Iron Refractory Iron-Deficiency Anemia (IRIDA). The study drug, ferric pyrophosphate citrate (FPC), is also called Triferic. It is an iron salt that has been approved by the Food and Drug Administration…
Condition: Addiction / Alcohol
Investigator: Gene Im, MD, FAASLD
Status: Closed
Researchers at Columbia University Irving Medical Center are investigating whether the investigational medication efimosfermin is safe and effective in improving outcomes for adults with Alcohol-related Liver Disease (ALD). ALD refers to liver damage caused by heavy alcohol consumption. The study uses a placebo for comparison because there are no approved…